| |
| |
|
| Insider
Information: |
Yancopoulos George |
| Relationship: |
Bd. Co-Chair, Presiden... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
786,383 |
|
|
Indirect Shares
|
362,461 |
|
|
| Direct
Value |
$770,781,161 |
|
|
|
Indirect Value
|
$355,269,774 |
|
|
| Total
Shares |
1,148,844 |
|
|
| Total
Value |
$1,126,050,935 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Bd. Co-Chair, Presiden... |
2024-05-16 |
786,383 |
2024-05-16 |
362,461 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-06-21 |
4 |
AS |
$532.89 |
$43,112,141 |
I/I |
(80,000) |
2,108 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2021-01-12 |
4 |
GA |
$0.00 |
$0 |
I/I |
82,108 |
82,108 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-02-12 |
4 |
AS |
$317.82 |
$28,504,985 |
D/D |
(88,987) |
1,068,343 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2017-12-14 |
4 |
GA |
$0.00 |
$0 |
I/I |
89,264 |
244,670 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2017-12-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
89,264 |
500,847 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2016-12-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
89,427 |
159,324 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2016-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
89,427 |
500,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-04-13 |
4 |
OE |
$10.56 |
$955,360 |
D/D |
90,444 |
157,540 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2015-10-30 |
4 |
D |
$559.08 |
$53,739,888 |
D/D |
(96,122) |
586,696 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2008-12-16 |
4 |
OE |
$7.41 |
$741,000 |
D/D |
100,000 |
636,103 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO & Pres Regn Res Labs |
• • – |
2009-12-03 |
4 |
OE |
$8.77 |
$877,000 |
D/D |
100,000 |
688,235 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2013-05-07 |
4 |
S |
$261.66 |
$26,263,581 |
D/D |
(100,000) |
1,106,395 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-02-11 |
4 |
D |
$314.31 |
$31,580,612 |
D/D |
(100,476) |
1,157,330 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2018-08-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
101,187 |
75,036 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2018-08-03 |
4 |
GA |
$0.00 |
$0 |
I/I |
101,187 |
487,141 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2013-05-06 |
4 |
D |
$260.44 |
$26,888,607 |
D/D |
(103,243) |
1,206,395 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2016-12-15 |
4 |
D |
$380.09 |
$40,157,269 |
D/D |
(105,652) |
591,348 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CSO |
• • – |
2017-12-13 |
4 |
D |
$385.08 |
$40,885,484 |
D/D |
(106,174) |
680,612 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-03-10 |
4 |
AS |
$461.79 |
$55,428,041 |
D/D |
(117,815) |
517,799 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2020-02-24 |
4 |
AS |
$420.17 |
$49,631,741 |
D/D |
(118,123) |
517,799 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2018-12-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
118,993 |
0 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2018-12-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
118,993 |
602,594 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CSO |
• • – |
2024-02-15 |
4 |
D |
$953.83 |
$117,894,342 |
D/D |
(123,601) |
801,608 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and Chief Scientific |
• • – |
2018-12-13 |
4 |
D |
$377.31 |
$47,184,502 |
D/D |
(125,055) |
118,993 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2003-09-17 |
4 |
OE |
$4.00 |
$535,568 |
D/D |
126,310 |
172,948 |
|
- |
|
145 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
